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Background: Spider silk is a tear-resistant and elastic biopolymer that has outstanding mechanical properties.
Additionally, exiguous immunogenicity is anticipated for spider silks. Therefore, spider silk represents a potential
ideal biomaterial for medical applications. All known spider silk proteins, so-called spidroins, reveal a composite
nature of silk-specific units, allowing the recombinant production of individual and combined segments.
Results: In this report, a miniaturized spidroin gene, named VSO1 that contains repetitive motifs of MaSp1 has
been synthesized and combined to form multimers of distinct lengths, which were heterologously expressed as
elastin-like peptide (ELP) fusion proteins in tobacco. The elastic penetration moduli of layered proteins were analyzed
for different spidroin-based biopolymers. Moreover, we present the first immunological analysis of synthetic
spidroin-based biopolymers. Characterization of the binding behavior of the sera after immunization by competitive
ELISA suggested that the humoral immune response is mainly directed against the fusion partner ELP. In addition,
cytocompatibility studies with murine embryonic fibroblasts indicated that recombinant spidroin-based biopolymers, in
solution or as coated proteins, are well tolerated.
Conclusion: The results show that spidroin-based biopolymers can induce humoral immune responses that are
dependent on the fusion partner and the overall protein structure. Furthermore, cytocompatibility assays gave no
indication of spidroin-derived cytotoxicity, suggesting that recombinant produced biopolymers composed of
spider silk-like repetitive elements are suitable for biomedical applications.
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Recent biomedical developments in the field of tissue
engineering require protein-based biomaterials as scaf-
folds that have been optimized for substantial extensibil-
ity, long-term stability, self-assembly and low energy loss
[1]. Further important properties are biocompatibility
and economical production, as well as purification sys-
tems, which could be provided by plant-based production
of elastin-like peptide (ELP) fusion proteins, referred to as
ELPylated proteins [2,3]. Since ancient times, spider silk
has been known for its extraordinary properties. Bygone
cultures used the secretory product of the spider spinning
glands. For example, Ancient Greeks were aware of the
boosting effect for wound healing and used spider webs to
cover bleeding lesions [4]. Today, spider silk is known to* Correspondence: conradu@ipk-gatersleben.de
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unless otherwise stated.promote the regeneration of nerves [5], and supports the
proliferation of fibroblasts and keratinocyte cell lines [6].
In addition to these fascinating features, the lightweight
and flexible biopolymer spider silk joins mechanical prop-
erties such as high toughness, tensile strength and stiffness
that competes with man-made polymers [7].
Spider silks produced by orb-web-weaving spiders are
composed of proteins that are commonly termed spi-
droins. An intensively investigated silk is the major ampul-
late silk, which is used by spiders as a structural element
to build the web frame and the safety line; therefore, it
is also called dragline silk. The well-known structure of
major ampullate silk consists of two proteins called major
ampullate spidroin 1 (MaSp1) and major ampullate spi-
droin 2 (MaSp2) [8]. The first partial sequence informa-
tion from MaSp1 of Nephila clavipes was published in
1990 and revealed a high repetitive primary structure
[9]. The protein consists of poly(A) blocks alternating
with GGX (X = Y, L, Q) and (GA)n sequence motifsntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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motifs in the core sequence is known as the key feature
of spidroins. Clearly there is a strong relationship between
the secondary structure, based on the unique motifs in the
primary protein structure, and the outstanding properties
of spider silks. The alanine-rich peptide regions form a
β-sheet that provides remarkable strength to major ampul-
late silk [11]. Conversely, the high toughness arises from
the glycine-rich peptide motifs, which likely induce the
formation of β-turns and 310 helices [7,12]. For the spi-
droin MaSp1, a molecular weight of up to 320 kDa is
reported [13]. It is assumed that the size of spider silk
proteins is a key factor in defining their mechanical prop-
erties, because all characterized native spider silks consist
of proteins with high molecular weights [13].
The usage of native spider silk on a larger scale is not
economically profitable. Currently, heterologous spidroin
production is the method of choice to satisfy the demand
of recombinant spider silk for research. For this purpose,
the most widely used host system is the gram-negative
bacterium Escherichia coli. Here, spider silk protein
modules of mainly a low molecular weight, approximately
50 kDa, were produced [14-17]. However, heterologous
expression of recombinant spider silk proteins in E. coli
was found to be rather inefficient owing to the low pro-
duction rate and instability of the spider silk gene [18]. Be-
cause of the highly repetitive nature of the proteins, DNA
deletion in the spider silk gene, as well as transcription
and translation errors were often observed during the
reproduction of recombinant E. coli harboring the gene
[19]. Furthermore, translational errors of proteins were
caused by a depletion of the t-RNA pool owing to the high
alanine and glycine content. Recently, expression of high
molecular weight spider silk derivatives up to 285 kDa has
been achieved by optimizing the glycyl-tRNA amount and
glycine synthesis [20]. Other expression systems used for
heterologous spidroin production are yeast [21], plants
[22,23], insects [24] or mammalians [25].
The knowledge of the molecular structure of spider
silk has inspired researchers to use the repeated modules
of silks to develop synthetic spidroins. In addition, an ap-
proach using a synthetic gene can avoid the abovemen-
tioned difficulties during heterologous expression of spider
silk proteins. The adaption of the codon usage to the t-
RNA pool of the intended host system is a considerable
advantage of synthetic genes. Furthermore, restriction
sites necessary for cloning into expression vectors can
be attached during gene synthesis and, therefore, prevent
additional PCR reactions that often cause errors with
highly repetitive genes. In previous studies, the synthetic
spider silk protein SO1, which shows a 94% homology
to MaSp1 of the golden silk spider, was successfully
expressed in plants (Nicotiana tabacum, Solanum tubero-
sum) [22]. For further investigations, this synthetic spidroinwas fused to 100 repeats of ELP to facilitate the purifi-
cation of plant-produced spider silk-like proteins [26]. In
addition, for other spider silk proteins ELPylation is a power-
ful technology for easy and economical purification [27].
In general, low immunogenicity is anticipated for highly
repetitive proteins such as spider silk derivatives and ELP
[28]. Here, we designed various synthetic spidroin-based
fusion proteins consisting of several repetitive motifs of
SO1 and accordingly MaSp1 termed (VSO1)n-100xELP.
We have designed these artificial fusion proteins to
produce material for tissue engineering with suitable
mechanical properties, low immunogenicity and cyto-
compatibility. After heterologous expression in plants,
the spidroin-based fusion proteins were purified by a
scalable and economical downstream processing proced-
ure. Furthermore, these synthetic spidroins were used to
analyze their mechanical properties and immunogenicity.
By producing recombinant spider silks in different for-
mats, the main requirements for biomedical applications,
including biocompatibility, sufficient mechanical proper-
ties in terms of elasticity, hardness and stiffness, and low
or even no immunogenicity, are met. Biocompatibility is
defined as the quality of the biomaterial as not being toxic
or having injurious effects on biological systems [19]. In
the present paper we have measured the cytocompatibility
with murine embryonic fibroblasts as an approach to esti-
mate biocompatibility. Finally, we discuss the suitability of
the different recombinant synthetic spider silk proteins for
biomedical applications.
Results
Recombinant production of synthetic spidroin-based
fusion proteins
Four different plant expression vectors coding for spidroin-
based fusion proteins varying in the spidroin content
have been designed to assess the mechanical properties,
immunogenicity and cytotoxicity in relation to the protein
size. Therefore, we created the synthetic spidroin gene
VSO1 containing characteristic repetitive motifs of MaSp1
and SO1, respectively, which were used as model proteins
for the blueprint. The synthesized gene was flanked by
compatible but non-regenerative restriction sites (BamHI
and BglII) to enable the insertion of further synthetic
genes for extension of the spidroin content. The resulting
recombinant proteins contained the typical sequence
motifs GGX, (GA)n and polyA blocks of MaSp1 in the
primary sequence (Figure 1A). Additionally, the synthetic
spidroin genes were combined with the gene encoding for
the biopolymer 100xELP in an expression vector to facili-
tate ubiquitous expression in transgenic tobacco. For the
retention of the recombinant proteins in the endoplasmic
reticulum (ER), the expression cassette also contained the
signal peptide (SP) LeB4 [29] and the ER retention signal
KDEL [30] (Figure 1A). Thus, four different synthetic
Figure 1 Expression of spidroin-based fusion proteins (VSO1)n-100xELP in transgenic tobacco plants. A) Protein sequence of VSO1 and
schematic representation of the plant expression cassette for (VSO1)n-100 × ELP. In the protein sequence, repetitive motifs are highlighted in red
and blue. Heterologous expression of synthetic spidroin (VSO1)n fused to 100 repeats of elastin-like peptide (100xELP) was controlled by the CaMV
35S promoter. SP: legumin B4 signal peptide; KDEL: ER retention signal; c-myc: detection tag. B) Immunoblot of leaf extracts from transgenic tobacco
expressing spider silk fusion proteins of different sizes. Samples of 5 μg of total soluble protein were applied to the gel and separated by 8% SDS-PAGE,
blotted and detected with an anti-c-myc antibody. WT: wild type N. tabacum cv. SNN. C+: 1 ng c-myc immunoblot standard anti-TNF-VHH-100xELP.
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molecular weights of 56 kDa (1xVSO1-100xELP), 69 kDa
(2xVSO1-100xELP), 83 kDa (3xVSO1-100xELP) and
96 kDa (4xVSO1-100xELP). Initially, each expression
vector was individually transformed into Agrobacterium
tumefaciens (A. tumefaciens), followed by the generation
of transgenic tobacco (Nicotiana tabacum) by leaf disc
transformation. After selection of kanamycin-resistant
tobacco plants, expression of fusion proteins was proven
by immunoblotting. Analyzed leaf extracts showed the
appropriate size increase from 1xVSO1-100xELP to
4xVSO1-100xELP (Figure 1B). The molecular weights
were determined by SDS-PAGE and, accordingly, im-
munoblotting. Protein sizes appeared higher than the
calculated masses, a phenomenon that was also observed
for other ELP fusion proteins [31,32].
The principal reason for fusion of the synthetic spidroins
to 100 repeats of ELP was to enable the chromatography-
free purification by inverse transition cycling (ITC) [26,33],
a low cost method for recovery of biopolymers. Here, syn-
thetic spidroin-based fusion proteins were purified fromFigure 2 AFM topographic images of spidroin-based biopolymer laye
2.5 × 2.5 μm2 scan sizes of A) 1xVSO1-100xELP, B) 2xVSO1-100xELP and C)tobacco leaves of transgenic plants via an advanced mem-
brane based ITC [34], which was optimized for spider silks
and performed according to Weichert et al. [27]. A heat
incubation step at the beginning of the purification
procedure leads to denaturation of the majority of the
proteins. In the following cooling step (4°C), all fusion
proteins became soluble and were separated by centrifu-
gation and enriched by filtration after several temperature
shifts. For further investigations purified proteins were
analyzed as casted layers or in solution.
Mechanical investigation of synthetic spidroin-based
biopolymer layers
Based on freshly prepared and smooth layers of the syn-
thetic biopolymers 1xVSO1-100xELP, 2xVSO1-100xELP
and 4xVSO1-100xELP, we performed Atomic Force
Microscopy (AFM) based nanoindentation experiments
to examine the relevance of the increasing spidroin
content. Figure 2 shows the corresponding topographic
images with the z-ranges of 9.6 nm (1xVSO1-100xELP),
7.4 nm (2xVSO1-100xELP) and 11.4 nm (4xVSO1-100xELP),rs. Surfaces have been taken in the intermitting tapping mode using
4xVSO1-100xELP.
Table 2 Elastic penetration moduli of recombinant
spidroin-based fusion protein layers
Substance Elastic penetration modulus E (GPa)
1xVSO1-100xELP 2.73 ± 0.02
2xVSO1-100xELP 3.85 ± 0.02
4xVSO1-100xELP 4.51 ± 0.03
LDPE Riblene®FL30 0.172 ± 0.001
GPa: Gigapascal; ELP: elastin-like peptide.
Values were obtained by AFM-based nanoindentation under the following
conditions: temperature = 23°C, relative humidity = 35%, system sensitivity =
22.5 nm/V, spring constant = 59.3 N/m, tip radius = 112 nm, setpoint control = 500
nN, relative setpoint = 2500 nN, z-closed loop active, z-length= 1 μm, retract delay =
10 ms, grid size = 25 × 25 μm2, data point 35 × 35 per run with an orthogonal and
lateral inter-sampling point distance of at least 715 nm. Low density polyethylene
(LDPE) Riblene® FL30 foil was used as reference.
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amorphous regions. It should be emphasized here that
the roughness of the examined layers is very low, with
roughness values < 2 nm (Table 1), fulfilling the pre-
sumption for AFM-based nanoindentation to examine
the elastic penetration modulus E and therefore, the
characterization of the stiffness of the biopolymer layers. In
former studies we showed on the basis of layers prepared
from a monomeric tagged spider silk protein (MaSp1)
fused to 100 repeats of ELP in comparison to layers
consisting of multimers of this protein that the elastic
penetration modulus E increased by multimerization [27].
In this mentioned experiment, the mass relation between
the spider silk part and ELP remains unchanged during
the multimerization process. In the present study, the
determination of the elastic penetration modulus E of
biopolymer layers varying in the spidroin content en-
abled a more detailed characterization of the relation
between the molecular weight of the whole biopolymer
and the spidroin content. Experiments were performed
at thin layers of each casted layer with a thickness of at
least 1 μm and a mean surface roughness smaller than
2 nm for 2.5 × 2.5 μm2 grids (Table 1). The E values
presented in Table 2 are significantly different, as tested
by the differential t-test [35]. It is important to notice
that the E values of 2xVSO1-100xELP and 4xVSO1-
100xELP were found to be considerably higher than
this of 1xVSO1-100xELP. In comparison, AFM-based
nanoindentation analyses of the fusion protein 100xELP
revealed an E value of 2.74 GPa [27]. The differences
between all mean values of the penetration modulus E
are highly significant. It can be assumed that the increase
of the spidroin content in the fusion proteins leads to an
ascending E value, and therefore represents a higher
stiffness of these materials.
To study in greater detail the influence of the increasing
spidroin content in these ELPylated recombinant proteins,
analyses of immunogenicity and cytotoxicity were per-
formed and related to their potential use as biomaterials.
Immunogenicity of synthetic spidroin-based fusion
proteins 1xVSO1-100xELP and 4xVSO1-100xELP
The use of spider silk variants for the production of pro-
tein scaffolds for tissue engineering or for engineering of









Defined grids of 2.5 × 2.5 μm2 were analyzed.that do not induce immune responses. Natural spider
silks do not cause an inflammatory response [36]. A low
immunogenicity for 100xELP is anticipated [28], and has
been shown experimentally by studying the T-cell re-
sponse [32]. In this report, we ask the question whether
different-sized fusion proteins of synthetic spidroins and ELP
can induce a humoral immune response and if the increas-
ing spidroin content in addition to the higher molecular
weight has an influence. For the determination of the im-
munogenicity elicited by heterologous synthetic spidroin-
based biopolymers one group of C57BL/6 J mice (animals
1–4) was immunized with 1xVSO1-100xELP and another
(animals 5–8) with 4xVSO1-100xELP. After the fourth
immunization, the immune responses in mice were deter-
mined by an indirect ELISA against the injected antigen
(Figure 3A and B). All sera showed a strong immune re-
sponse against their antigen, but the antisera raised against
the 4xVSO1-100xELP showed binding at higher dilutions,
indicating a stronger immune response. Cross-reactivity
against the other antigen with a different molecular weight
was detected; however, this was very low (Figure 4). We
next asked the question if this relative specificity is due to
specific structural epitopes formed by the different fusion
proteins and we also wanted to explain cross-reactivity.
For further immunological analyses, serum 1, which was
isolated from a mouse immunized with 1xVSO1-100xELP,
and serum 5, which was from a mouse that had been
immunized with 4xVSO1-100xELP, were selected. First
we analyzed whether the immune response was directed
against the spidroin region (VSO1), against the c-myc tag
and/or against ELP. For this purpose 1xVSO1-100xELP,
4xVSO1-100xELP, 100xELP and the recombinant protein
anti-TNF-VHH [37], containing a c-myc tag, were in-
cluded into the immunoblotting analyses. Additionally,
the immune response to the fusion protein anti-TNF-
VHH-100xELP [37], which also contained the c-myc tag,
was analyzed. All proteins were synthesized in planta.
After developing immunoblots with the appropriate mouse
serum, synthetic spidroins were detected, along with anti-
Figure 3 Specific immune response of mouse sera determined by indirect ELISA. Samples of 500 ng per well of A) 1xVSO1-100xELP and B)
4x VSO1-100xELP were coated to a microtiter plate and the reaction against mouse sera was analyzed for different dilutions. The antigen-antibody
complex was detected using goat anti-mouse IgG conjugated with alkaline phosphatase. Extinction was measured at 405 nm (ordinate).
Figure 4 Determination of the cross-reaction of mouse sera by
indirect ELISA. Antigens 1xVSO1-100xELP and 4xVSO1-100xELP were
coated and the cross-reaction against the other antigen was analyzed.
Mouse sera specific against 1xVSO1-100xELP were applied at a dilution
of 1:2000 and mouse sera specific against 4xVSO1-100xELP were
diluted at 1:5000. Extinction was measured at 405 nm (ordinate).
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and B). Anti-TNF-VHH was not recognized by sera iso-
lated from immunized mice, but it was detected by im-
munoblotting with the anti-c-myc antibody, implicating
that the c-myc tag did not induce an immune response
(Figure 5A-D). All other proteins mentioned here con-
tained a c-myc tag and were detectable via immuno-
blotting using an anti-c-myc antibody (Figure 5C and D).
After incubation with mouse normal serum, no nonspe-
cific reaction was detectable (Figure 5E and F). The
relative specificity for the proteins used for immunization
could not be seen after immunoblotting. Serum 1 and
serum 5 showed comparable binding behavior (Figures 5
and 6). With serum 1 against 1xVSO1-100xELP it was also
possible to detect 4xVSO1-100xELP. Analogous antigen-
antibody recognition occurred for serum 5 and 1xVSO1-
100xELP. The epitopes responsible for relative specificity
against the injected proteins in the indirect ELISA are
possibly destroyed by denaturation during SDS-PAGE.
Figure 5 Comparative immunoblots of the immune response of plant-expressed biopolymers to different antibodies. Recombinant proteins
were separated on 12% SDS-PAGE, electrotransferred and detected with A)mouse serum number 1, B) mouse serum number 5, C) and D) anti-c-myc
monoclonal antibody, and E) and F) mouse normal serum.
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significant binding to 100xELP in immunoblotting ana-
lysis and to anti-TNF-VHH-100xELP (Figure 6A and B).
Here, we analyzed the binding to ELP in more detail. Poly-
clonal antibodies are a mixture of different antibodies by
nature, with their own respective kinetic characteristics
and, in many cases, with differences in epitope specificity.
Based on this heterogeneity, the rate constants derived
and affinities calculated based on such measurements
should be regarded as a mean of different subpopulations.
In the case of ELP, the number of different epitopes is lim-
ited, because it is a highly repetitive protein consisting
of pentamers of very similar if not equal amino acid se-
quences. Therefore, the complexity is also limited and
calculation of a mean dissociation constant Kd is a usefultool to characterize the immune response against ELP-
based epitopes. For the selected sera, optimal antigen
concentrations were predetermined in dilution analyses
and further evaluation of the immunogenicity of ELP
was performed by a competitive ELISA. For this purpose,
1xVSO1-100xELP and 4xVSO1-100xELP, respectively, was
adsorbed to the polystyrene surface and the binding of the
relevant antisera was measured. This binding was inhibited
by competition with 100xELP. The calculated mean dis-
sociation constant Kd for the complex 1xVSO1-100xELP-
anti 1xVSO1-100xELP from animal 1 and the competitor
100xELP was 25 nM (Figure 7A) and the mean Kd for
4xVSO1-100xELP-anti 4xVSO1-100xELP from animal 5
and 100xELP was 374 nM (Figure 7B). In the immuno-
genic 1xVSO1-100xELP, the relative ELP content is much
Figure 6 Immunoblots for the characterization of the capability for cross-reaction of antigens with serum from other spidroins. Both
spidroin-based biopolymers, 1xVSO1-100xELP and 4xVSO1-100xELP, and the control proteins, anti-TNF-VHH, anti-TNF-VHH-100xELP and 100xELP,
were separated using 12% SDS-PAGE, electrotransferred and detected with A) mouse serum 1 or B) mouse serum 5.
Figure 7 Characterization of the immune response to ELP by
competitive ELISA. Analyses for a complex consisting of A)
1xVSO1-100xELP and mouse serum 1 competing to 100xELP and
B) 4xVSO1-100xELP, and mouse serum 5 competing to 100xELP.
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affinity) to ELP was induced. However, we cannot exclude
that the position of the ELP part in the resulting protein
structure of the fusion protein is different in 1xVSO1-
100xELP and 4xVSO1-100xELP. The competition curves
showed that binding to 1xVSO1-100xELP and to 4xVSO1-
100xELP could be completely inhibited (Figure 7). This
implicates that the humoral immune response is mainly
directed against 100xELP. An overview of all analyzed
immune responses is given in Table 3.In vitro cytotoxicity assays of the synthetic spidroin-based
biopolymers 1xVSO1-100xELP and 4xVSO1-100xELP
At first, cytotoxicity of the synthetic spidroins fused to
ELP was assayed with soluble and coated proteins. In gen-
eral, cell metabolic activity is determined as an indirect
measure for cell vitality and proliferation. This is done by
adding a compound to the culture medium, which is me-
tabolized by the living cells to a fluorescent end product.
Here, the influence of a recombinant spider silk protein
on the metabolism of murine embryonic fibroblasts was
tested by adding the protein to the cell culture medium
or by coating the culture surface. In both cases an influ-
ence could be observed. 1xVSO1-100xELP and 4xVSO1-
100xELP significantly stimulated the cells when metabolic
activity was determined 24 hours after the addition of the
protein (Figure 8A). The same trend was observed on day
three; however, now the only statistically significant differ-
ences were between 100xELP and 1xVSO1-100xELP and
4xVSO1-100xELP, respectively (Figure 8B). The results
for cells grown on protein-coated surfaces were similar
(Figure 9A and B), although a significant effect was detect-
able later (Figure 9B).











1xVSO1-100xELP (56 kDa) + + + -
4xVSO1-100xELP (96 kDa) + + + -
anti-TNF-VHH (15 kDa) - - + -
anti-TNF-VHH-100xELP (57 kDa) + + + -
100xELP (42 kDa) + + + -
A positive reaction is labeled with a plus sign and no reaction is marked with
a bar.
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fusion protein 100xELP was evaluated by direct hemolysis
testing. The possible destruction of the erythrocyte mem-
brane was measured by determining the amount of
free plasma hemoglobin (Hb). The results showed that
100xELP was not hemolytic when covered on glass cover-
slips. While 100% relative hemolysis could be achieved in
the samples containing catheters as a positive control the
relative hemolysis observed in the samples with protein-
coated glass coverslips were in the same range as the
samples obtained by testing blood on high density poly-
ethylene films used as the negative reference material
(Figure 10). In general, the results of these cytotoxicity
analyses examining cytotoxicity and hemocompatibility
provided a positive preliminary indication for the use of
the investigated synthetic spidroin-based biopolymers in
medical applications.
Discussion
The high molecular weight of spider silk proteins is as-
sumed to be a key factor that underpins their outstandingFigure 8 Metabolic activities of murine embryonic fibroblasts in cont
medium supplemented with the indicated recombinant protein for 24 hou
three independent repeats (n = 8, mean and SEM).mechanical properties, because all characterized native
spider silks consist of proteins with high molecular
weights [13]. In this study, we analyzed the relation of
the spidroin content in recombinant spidroin-based bio-
polymers and the corresponding mechanical properties.
The elastic penetration modulus E was found to range
from 2.7 GPa for 1xVSO1-100xELP to 4.5 GPa for
4xVSO1-100xELP; the synthetic biopolymer with the
highest molecular weight that was used in this study.
The significant increase of the elastic penetration modulus
E, which correlates in a first approximation with the
Young’s modulus, appears to be due to the increase in
the spidroin content. E values were also comparable to
ELPylated MaSp1 derivatives, which were previously in-
vestigated [27]. One must take into account that the re-
combinant spidroin-based biopolymers analyzed here
has approximately one-third of the molecular weight of
the native MaSp1 and that protein layers were exam-
ined. In comparison, for native dragline silk a Young’s
modulus of approximately 12 GPa was determined [20].
Additionally, the mechanical characterization of a fiber
made from native-sized recombinant spider silk protein
showed a Young’s modulus of 21 ± 4 GPa; however, in
the same study it was also noted that proteins of lower
molecular weight did not yield similar material proper-
ties [20]. Therefore, for further intended projects the
production of native-sized spidroin containing biopoly-
mers is commendable and has already been successfully
performed in planta with an intein-based post-translational
protein multimerization technology [38].
Low immunogenicity is anticipated for natural spider
silks; this feature was exemplarily proven for major ampul-
late dragline silk collected from Nephila clavipes [39].act with soluble synthetic biopolymers. The cells were cultured in
rs (A) or 72 hours (B). The graphs depict a representative result of
Figure 9 Metabolic activities of murine embryonic fibroblasts in contact with coated synthetic biopolymers. The cells were cultured on
surfaces coated with the indicated recombinant protein for 24 hours (A) or 72 hours (B). The graphs depict a representative result of three
independent repeats (n = 8, mean and SEM).
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body response to a spidroin-based biopolymer, which
was enabled by a collection of various mouse sera that
were prepared after immunization of mice with soluble
spidroin-ELP fusion proteins. The spidroin-based pro-
teins additionally contain the c-myc tag. An immune
response against the c-myc-tag could not be detected
by immunoblotting. All the antigens used in the im-
munological analyses were produced in plants to allow
comparisons in all experiments. The data found by
indirect ELISA showed a relative specific reaction
against the immunogen, either 1xVSO1-100xELP orFigure 10 Hemolysis of human erythrocytes incubated with
100xELP. The biopolymer was coated on glass coverslips. Free Hb
was determined and expressed as percent of the positive control (n
= 3, mean and SEM).4xVSO1-100xELP. This data provides no insight into
whether these specific antibodies in the sera bind to
ELP- or spidroin-based epitopes or new overall struc-
tures in the different fusion proteins. After denatur-
ation of the antigens and SDS-PAGE, the specific
reactions were not observed in the immunoblotting ex-
periments. Competitive ELISA data showed clearly that
binding is completely inhibited by 100xELP. We conclude
that the humoral immune response against the spidroin-
based polymers is directed against epitopes involving
100xELP. The sera raised against 1xVSO1-100xELP bind
to 100xELP with a > 15-fold higher mean dissociation
constant. These differences in the affinity against ELP
support the view (see above) that 1xVSO1-100xELP and
4xVSO1-100xELP induced antibodies against different
epitopes. These antibodies with higher mean affinity could
be induced either by the higher ELP proportion in the
fusion protein compared with 4xSO1-100xELP or by spe-
cific structures occurring in the 1xVSO1-100xELP fusion
protein. We conclude that, in general, spidroin-based bio-
polymer variants have to be tested according their im-
munogenicity in each single case. The structure of fusion
proteins could lead to the induction of several new im-
mune responses even if standard basic sequences are used.
Cytocompatibility is a prerequisite for the biomedical
application of a material. Therefore, in vitro cytotoxicity
assays are typically one of the first assessments carried
out in the biological evaluation of biopolymers. Recom-
binant spider silk proteins have been tested in a number
of different settings. In previous studies, it was shown that
a plant-produced synthetic spidroin derived from MaSp1
and fused with hundred repeats of elastin-like peptides
(ELP) resulted in a non-cytotoxic biopolymer that sup-
ported the proliferation of mammalian cells [26]. An
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of five glycine-rich segments alternating with four poly-
alanine stretches connected to a non-repetitive globular
C-terminal domain by a serine- and alanine-rich linker
produced in E. coli was tested with primary human fi-
broblasts. The cells attached to the material and grew
on different matrices such as meshes and foams [40].
3T3 fibroblasts adhered to porous scaffolds of recombin-
ant protein based on spidroin 1, even filling the deeper
layers after 14 days [41]. However, a recombinant protein
based on the silk of the European garden spider prevented
adhesion and cell proliferation of BALB/3 T3 fibroblasts
when coated on silicone surfaces [42]. Here, we found a
positive stimulation of cellular metabolism, which indi-
cates higher growth rates. This effect was dependent on
the composition of the protein. Interestingly, we could
even enhance the positive effect when the proteins were
freely available in the medium. Although, we cannot
rule out that this effect is based on the nutritive value
of the proteins, this is rather unlikely owing to the neg-
ligible concentration of the protein present.
Biomaterials in contact with blood must show good
hemocompatibility, which is often improved by coating.
Sulfated silkworm fibroin has been used for this pur-
pose in a study to enhance the hemocompatibility of
poly(lactic-co-glycolic) acid vascular grafts [43]. Never-
theless, it has been discussed that larvae from two pyra-
lid moths express silk proteins in their guts, their fat
body and their hemocytes. It is assumed that these pro-
teins also take part in immunity and coagulation [44].
We observed no hemolytic effect in the examined sam-
ples, indicating that they may serve as biocompatible
coatings of blood-exposed implants.
Synthetic spidroins as biomaterials that are produced
in biotechnology processes have potential use in a wide
range of biomedical material applications. Prominent
examples are scaffolds for tissue engineering (films,
sponges, hydrogels) and drug delivery systems that trig-
ger an effective immune response after vaccination with
particle bound antigens [45,46]. In this study, we partially
worked with casted proteins. Since the surface of the
resulting films showed a very low roughness, applications
as a coating or a wound dressing device is conceivable. Fi-
nally, the molecular weight of spidroin-based biopolymers
did not influence the cytocompatibility of the casted films.
Conclusion
The main goal of the present study was the assessment
of the immunological properties and cytotoxic effects
of synthetic spidroin-based fusion proteins expressed in
planta. Considering the rising elastic penetration modulus
determined by AFM-based nanoindentation with increas-
ing spidroin content, we assume additionally a first rela-
tionship between spidroin size and mechanical properties.All available antibody detection systems were used to
determine epitope regions, including detection of the c-
myc tag, characterization of mouse sera after immunization
with the synthetic spidroin-based biopolymers and per-
formance of competitive ELISA with the competitor
ELP. Furthermore, analyses of cross-reactivity experi-
ments gave no hint of an immunogenic region in the
synthetic spidroin part of the fusion constructs. In the
end, cytocompatibility studies provided no indication of
spidroin-derived cytotoxicity. This implies that these




Synthetic 1xVSO1 was produced by Geneart (Life Tech-
nologies, CA, USA) and contained repetitive gene mo-
tives from Nephila clavipes cDNA [GenBank: M37137.2].
In the course of the synthesis, the codon usage of syn-
thetic 1xVSO1 was adapted to N. tabacum. After restric-
tion digest with BamHI and BglII the gene fragment was
ligated into the vector 100xELP-pRTRA [47]. Further in-
sertion of synthetic genes was facilitated with an additional
restriction digest of the vector (VSO1)n-100xELP-pRTRA
with BamHI and ligation of a BamHI/BglII digested
1xVSO1 gene fragment. After ligation, a functional BamHI
restriction site was retained at the 5′-prime end of the
synthetic gene. The resulting plasmid (VSO1)n-100xELP-
pRTRA contained a plant expression cassette consisting of
the Cauliflower Mosaic Virus (CaMV) 35S promoter [48],
the legumin B4 signal peptide (LeB4) [29], the synthetic
gene (VSO1)n, a c-myc tag [49], 100 repeats of the fusion
protein ELP [26] and the ER retention signal KDEL [50].
The expression cassettes were excised with the restriction
enzyme HindIII and inserted individually into the binary
vector pCB301-Kan [51], resulting in the plant expression
vectors (VSO1)n-100xELP-pCB301-Kan.
Production of plant-expressed synthetic spidroin-based
fusion proteins
The binary vectors were transformed into the A. tumefa-
ciens strain C58C1 (pGV2260) [52] by electroporation.
For stable transformation of tobacco (N. tabacum cv. SNN),
the leaf disc transformation method reported by Horsch
et al. [53] was performed. The transgenic plants were
cultured on Murashige-Skoog agar containing 50 mg/L
kanamycin and analyzed by immunoblotting using an
anti-c-myc antibody [54]. High expressing plants were
cropped into soil and grown in a greenhouse for 4 to
6 weeks prior to harvesting the leaves. The fusion of the
synthetic spider silks to 100xELP enabled protein purifica-
tion via membrane-based inverse transition cycling (mITC)
[34]. Therefore, frozen leaf material (−80°C) was crushed,
added to preheated (85°C) 50 mM Tris–HCl (pH 8.0)
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desalting was performed as described [27]. For deter-
mining protein weight and storage, the purified proteins
(VSO1)n-100xELP were lyophilized (ALPHA2-4LSD;
Christ, Osterode, Germany).
SDS-PAGE and immunoblotting analysis
For analysis of transgenic plants, leaf material was ground
in liquid nitrogen. Sample buffer (72 mM Tris, 10% v/v
glycerol, 2% w/v SDS, 5% w/v 2-mercaptoethanol and
0.0025 mM bromphenol blue, pH 6.8) was added and the
homogenate was incubated for 10 min at 95°C. After
centrifugation (30 min, 4°C, 12,000 rpm), the extract
(supernatant) was kept and the protein concentration
was determined by Bradford assay (Bio-Rad, Germany).
Plant extracts or purified proteins, which were also ana-
lyzed by immunoblotting, were separated on reducing
SDS-PAGE and electroblotted to a nitrocellulose mem-
brane (Whatman GmbH, GE Healthcare, Germany) using
25 mM Tris, 0.1% w/v SDS, 192 mM glycine and 20% v/v
methanol. For detection of the transgenic product, the
membranes were blocked for 2 hours in 5% w/v fat-free
dry milk dissolved in 180 mM NaCl and 20 mM Tris,
pH 7.8. The primary antibody was either an anti-c-myc
(9E10) supernatant [54] or an anti-(VSO1)n-100xELP
mouse serum. Therefore, two groups of four mice each
(C57BL/6 J) were immunized with 1xVSO1-100xELP or
4xVSO1-100xELP. For the first immunization, 50 μg anti-
gen and complete Freund’s adjuvants (Difco, USA) were
used. In the following three immunizations animals were
boosted with 20 μg antigen and incomplete Freund’s
adjuvants (Difco, USA). Titers from blood samples were
evaluated by ELISA and sera were collected one week
after the fourth immunization. For immunoblotting analysis
the secondary antibody used was a horseradish peroxidase-
(HRP-) conjugated anti-mouse IgG from sheep (GE Health-
care UK Ltd., UK). Synthetic spidroin-based fusion proteins
were detected by ECL (Amersham ECL Plus TM, GE
Healthcare UK Ltd., UK).
Mechanical Testing of (VSO1)n-100xELP
Protein layers for AFM imaging and AFM-based nanoin-
dentation were casted by the drop to drop technique.
Therefore, proteins were solubilized in water to a concen-
tration of 1 mg/mL, successively dropped in 20 μL droplets
onto glass slides and dried in a vacuum (Vacuum Concen-
trator 5301; Eppendorf, Germany) at room temperature
until achieving layers of required thickness [27]. Measure-
ments of protein layer thicknesses and topographical
imaging were performed by an atomic force microscope
Nanowizard®II (JPK Instruments, Germany) using either
the Contact Mode with an MLCT silicon nitride cantilever
(Bruker Cooperation, USA) or silicon cantilevers PPP-
NCHR (NANOSENSORS™, NanoWorld AG, Switzerland)with tip radii below 7 nm for the Intermittent Contact
Mode. Based on topographical information, roughness data
were evaluated. AFM-based nanoindentation was per-
formed to assess the elastic penetration modulus E. For
that reason, the same AFM instrument was used to record
and evaluate load penetration curves according to an ad-
vanced Hertzian model for spherical indenter geometry
[27,55] as a course of the load dependent on a penetration
depth between 10 to 15 nm. E-values were calculated from
a large series of 1225 indentations, which were performed
for each protein layer with an orthogonal and lateral inter-
sampling point distance of 715 nm and this enabled the
statistically evident calculation of E for each material
(Additional file 1). Elastic penetration moduli E were
calculated from the recorded load penetration curves. Here,
a diamond-coated cantilever DT-NCHR #1 (NanoWorld
AG, Switzerland) calibrated by the Thermal Noise Method
was used. The exact geometry of the diamond-coated canti-
lever tips was checked by scanning electron microscopy
(SEM) before and after indentation measurements.
Indirect and competitive ELISA
For evaluation of the antibody titer against the specific
antigen and to examine the cross-reaction, an indirect
ELISA was performed. Ninety-six-well plates (MaxiSorp™
Surface, Thermo Scientific Nunc A/S, Denmark) were
coated overnight at room temperature with 500 ng of
synthetic spidroin dissolved in 100 μL phosphate-buffered
saline for phages (PPBS; 32 mM Na2HPO4 × 2 H2O,
17 mM NaH2PO4 ×H2O, 100 mM NaCl, pH 7.2). Bovine
serum albumin (BSA, 3% w/v) in phosphate-buffered
saline (PBS; 8 mM Na2HPO4 × 2 H2O, 2 mM KH2PO4,
150 mM NaCl) supplemented with 0.05% (v/v) Tween-
20 (PBS-T) was used as the negative control. Blocking
was done with 130 μL/well using 3% (w/v) BSA in PBS-T
(pH 7.6) for 2 hours at room temperature. Mouse sera
were diluted with 3% BSA in PBS-T as indicated in the re-
sults section and applied in triplicate using a volume of
100 μL/well on the coated plates for 1.5 hours at 25°C.
After five washing steps with PBS-T, a goat anti-mouse
IgG conjugated with alkaline phosphatase (Sigma, USA)
was added in a dilution of 1:2,000 in 1% (w/v) BSA-PBS-T.
Plates were incubated for 1 hour at 25°C followed by
five washing cycles with PBS-T. Bound antibodies were
detected after the addition of the substrate p-nitrophenyl
phosphate (1 mg/mL in 0.1 M diethanolamine-HCl,
pH 9.8). The reaction was incubated at 37°C and the
absorbance was measured at 405 nm within of 1 hour
of the reaction being initiated.
For the competitive ELISA, antigens were dissolved in
PPBS and 50 ng/well (1xVSO1-100xELP) or 100 ng/well
(4xVSO1-100xELP), respectively, were coated to the micro-
titer plates. Blocking and washing were performed as men-
tioned above. Various concentrations of the competitor
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mixed for 30 min at room temperature with either a
1:7,500 dilution of mouse serum 1 (against 1xVSO1-
100xELP) or a 1:4,000 dilution of mouse serum 5
(against 4xVSO1-100xELP). Both competition partners
were diluted in 3% (w/v) BSA in PBS-T. This premix
was added in quintuplicates to the coated plates followed
by incubation at 25°C for 1.5 hours; 3% BSA in PBS-T was
used as negative control. Further processing of the assay
was performed as described above.
Coating of the cell culture material for cytotoxicity tests
The synthetic spidroin-based biopolymers were diluted
to a concentration of 50 μg/mL with phosphate-buffered
saline without calcium and magnesium (PBS, Life
Technologies). Glass coverslips for direct hemolysis assay,
coated on both sides, and black microtiter plates for the
determination of cell metabolism were coated with the
protein by applying the protein solution at 4°C overnight.
The liquid was then removed and cell culture plates were
dried at room temperature. The coated materials were
kept at 4°C or used immediately. PBS without the biopoly-
mer was used as a control.
Cell metabolism assay
Murine embryonic fibroblasts were obtained from the
ATCC (ATCC® SCRC-1045™) and cultured in Dulbec-
co’s Modified Eagle’s Medium (DMEM) high-glucose
(Biochrom, Berlin Germany) with 1% penicillin/streptomycin
(Biochrom, Berlin Germany), 1% sodium pyruvate
(Biochrom, Berlin, Germany) and 10% fetal bovine
serum (Biochrom, Berlin, Germany). The cultures were
split thrice weekly and kept in a humidified atmosphere at
37°C and 5% CO2. For the measurements, the cells were
diluted to 5 × 104 cells/mL and seeded onto microtiter
plates. All test samples were done either on surface-coated
wells as indicated above or the protein was added to a
final concentration of 50 μg/mL to the culture medium.
After the indicated time points, 20 μL of CellTiter-Blue® solu-
tion (Promega, USA) was added to each well and incubated
at 37°C for 2 hours. Fluorescent resorufin was measured by
using 560 nm excitation and 590 nm emission filters. All
tests were repeated at two independent times and performed
at octuplicates. The data were analyzed by one-way ANOVA
followed by Tukey’s multiple comparisons test.
Preparation of blood
The blood was obtained from the Institut für Transfu-
sionsmedizin, Medizinische Hochschule Hannover. The
blood donors subscribed a declaration, that they agree that
small amounts of their blood could be used for research
proposals. Human blood was collected in S-Monovette
tubes (Sarstedt, Germany) with citrate and used within
4 hours after collection by pooling equal amounts ofblood. The Hb value of the pooled blood was measured
and the blood was diluted with PBS to a total blood Hb
concentration of 10 ± 1 mg/mL.
Direct hemolysis assay
The samples were covered with PBS resulting in a surface-
to-PBS ratio of 3 cm2/mL in screw-cap polypropylene
tubes. Subsequently, pooled blood was added at a ratio of
1:7 and incubated at 37°C for 3 hours. During this time,
the tubes were inverted carefully twice every 30 minutes.
A sample of 1.8 ml was removed from the test tubes and
centrifuged at 700–800 g for 15 minutes. Drabkin’s so-
lution (Sigma, Germany) was added to the samples at
equal volumes and incubated at room temperature for
15 minutes. Two aliquots of each sample were transferred
to a microtiter plate and the absorbance was measured at
540 nm. All measurements were done in triplicates and
catheters (ARROWg+ ard Blue, Arrow international) and
high density polyethylene films (RM-C, Hatano Research
Institute) were used as hemolytic and non-hemolytic
controls, respectively.
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